GLUT5 armouring enhances adoptive T-cell therapy anti-tumour activity under glucose-limiting conditions.
- DOI
- 10.1093/immadv/ltaf018
- Published
- 2025
- Container
- Immunotherapy advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/immadv/ltaf018,
title = {GLUT5 armouring enhances adoptive T-cell therapy anti-tumour activity under glucose-limiting conditions.},
author = {Page R and Martinez O and Larcombe-Young D and Bugallo-Blanco E and Papa S and Perucha E},
year = {2025},
journal = {Immunotherapy advances},
doi = {10.1093/immadv/ltaf018},
url = {https://doi.org/10.1093/immadv/ltaf018}
}RIS
TY - JOUR TI - GLUT5 armouring enhances adoptive T-cell therapy anti-tumour activity under glucose-limiting conditions. AU - Page R AU - Martinez O AU - Larcombe-Young D AU - Bugallo-Blanco E AU - Papa S AU - Perucha E PY - 2025 JO - Immunotherapy advances DO - 10.1093/immadv/ltaf018 UR - https://doi.org/10.1093/immadv/ltaf018 ER -
APA
R, P., O, M., D, L., E, B., S, P., & E, P. (2025). GLUT5 armouring enhances adoptive T-cell therapy anti-tumour activity under glucose-limiting conditions.. Immunotherapy advances. https://doi.org/10.1093/immadv/ltaf018
Source records
- pubmed · retrieved 2026-09-26T23:24:23.601Z